𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of interleukin-2 administration on platelet function in cancer patients

✍ Scribed by Leslie Oleksowicz; Dina Zuckerman; Zbigniew Mrowiec; Elena Puszkin; Janice P. Dutcher

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
715 KB
Volume
45
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Trends in the safety of high dose bolus
Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer
✍ Udai S. Kammula; Donald E. White; Steven A. Rosenberg πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 2 views

## BACKGROUND. Administration of recombinant high dose interleukin-2 (IL-2) can mediate tumor regression in patients with metastatic melanoma and renal carcinoma. Significant trends in the safety of high dose IL-2 administration at a single institution over a 12-year study period were reviewed. #

Influence of the administration schedule
Influence of the administration schedule on the therapeutic effect of interleukin-2
✍ Jan Vaage; John L. Pauly; James P. Harlos πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 French βš– 466 KB

The local and systemic therapeutic effects of multiple peritumoral injections of recombinant human interleukin-2 (IL-2) were tested against the syngeneic, immunogenic mammary carcinoma MC2 implanted subcutaneously into C3H/He mice. Multiple (12) low-dose injections had a greater local therapeutic ef

Effect of recombinant human erythropoiet
Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: Association with early improvement in platelet function
✍ TΓ ssies, Dolors; Reverter, Joan Carles; Cases, Aleix; Calls, Jordi; Escolar, Gin πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

Recombinant human erythropoietin improves platelet function in uremia through the correction of anemia, but this effect can be seen also before the hematocrit rise. We studied 12 hemodialyzed patients (seven men, five women) who received recombinant human erythropoietin (40 IU kg -1 i.v., three time